Trinity Biotech (TRIB) Interest Coverage Ratio Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) Interest Coverage Ratio Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -18.19% |
| Sep 30, 2024 | 22.54% |
| Jun 30, 2024 | 28.23% |
| Mar 31, 2024 | 66.63% |
| Dec 31, 2023 | 3.12% |
| Sep 30, 2023 | 29.33% |
| Jun 30, 2023 | 35.73% |
| Mar 31, 2023 | 24.46% |
| Dec 31, 2022 | -37.67% |
| Sep 30, 2022 | 37.11% |
| Jun 30, 2022 | 16.46% |
| Mar 31, 2022 | 15.87% |
| Dec 31, 2021 | -21.20% |
| Sep 30, 2021 | 2.48% |
| Jun 30, 2021 | 39.60% |
| Mar 31, 2021 | -10.48% |
| Dec 31, 2020 | -42.01% |
| Sep 30, 2020 | -22.25% |
| Jun 30, 2020 | 30.74% |
| Mar 31, 2020 | 62.31% |